麻豆传媒

Pharmacists debate the mixed science behind emerging therapy

Fremanezumab reduces migraine days among treatment-refractory patients

Anti-opioid attitudes have become 'weaponized,' expert says

Chronic pain patients were left out to dry

"Pain is fundamentally more than just biology," says Beth Darnall of Stanford

Framework won't vary with 'swirling' political or regulatory climate

More patients complete treatment period with lofexidine, studies say

But concerns emerge about upper respiratory infections

Patients fail to ID these drugs or associated risks

Defective activity levels require extra meds for pain control

Study finds excess costs ramp up before the initial diagnosis

Majority of patients on lowest dosage per day